Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy

Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy

Background: we aimed to assess the influence of metabolic syndrome on fibrosis regression (using liver-stiffness measurement (LSM) and serological scores) and the relationship with the expression of lysyl oxidase-like-2 as a potential goal of antifibrotic therapy. Methods: We included 271 patients t...

Full description

Bibliographic Details
Main Authors: Angela Puente, Jose Ignacio Fortea, Miguel Posadas, Agustin Garcia Blanco, Laura Rasines, Joaquin Cabezas, Maria Teresa Arias Loste, Susana Llerena, Paula Iruzubieta, Emilio Fábrega, Javier Crespo
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Journal of Clinical Medicine
Subjects:
SVR
liver fibrosis
LOXL2
portal hypertension
fibrosis regression
Online Access:https://www.mdpi.com/2077-0383/8/8/1242

Internet

https://www.mdpi.com/2077-0383/8/8/1242

Similar Items